Pharma Medical Affairs 2020 and beyond

You may also like

• 
  LEK

  Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and postapproval activities.

  

  Artificial Intelligence in Life Sciences

  $0.00 LEK
  
• 
  ORBIT2transformation

  To get a sense of the potential of digitization in procurement, picture this: It’s 2020. Hybrid cloud solutions, RPA and blockchain are in place. P2P is highly streamlined with zero-touch options. As a next-gen Chief Procurement Officer, your day starts with browsing through a virtual supplier screen that displays a status report on expiring contracts, feedback from suppliers on contractual negotiations, RFX launched on open markets and so on.

  

  Procurement 4.0 Preparing for Digital Transformation

  $0.00 ORBIT2transformation
  
• 
  Oliver Wyman

  In this year’s State of Financial Services report we examine the potential for the industry to start again. We explore the power of new – areas in the industry where new technology and businesses are having a proven impact. We show how existing firms can deploy a greenfield approach to deliver new growth and to accelerate transformation of the existing business.

  

  The State of the Financial Services Industry 2019: Time to Start again

  Rated 4.00 out of 5
  $0.00 Oliver Wyman